• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Higher rate of adverse events following abortion induced by mifepristone-misoprostol than procedurally

byDavid XiangandKiera Liblik
January 10, 2023
in Emergency, Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Mifepristone-misoprostol-induced abortions (IA) were associated with a higher risk of short-term adverse events than procedural IA in female patients up to 14 weeks of gestation.

2. Mifepristone-misoprostol IA was associated with a higher risk of an emergency department (ED) visit than procedural IA.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Procedural (surgical) IA is the conventional approach for pregnancy termination in the first trimester. Though, access to procedural IA can be challenging due to geographic barriers, local legislation, long wait times, and the need for self-referral. Mifepristone-misoprostol IA has been developed and introduced as an alternative. This oral medication has an efficacy of about 97% when used before 10 weeks gestation. However, there is a gap in knowledge as to understanding the short-term risk for adverse outcomes for this option. The relative safety and efficacy of mifepristone-misoprostol compared to procedural IA have not yet been evaluated in head-to-head trials. Overall, this study found that mifepristone-misoprostol IA resulted in more short-term adverse events than procedural IA, though the risk for serious adverse outcomes was very low. This study was limited by not assessing long-term outcomes, including future fertility and pregnancy outcomes. Nevertheless, these findings are significant, as they demonstrate that short-term adverse events are more likely to occur in mifepristone-misoprostol IA as compared to procedural IA.

Click to read the study in AIM

Relevant Reading: The War on Reproductive Health Care in the United States

RELATED REPORTS

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

Maternal hypertension associated with adverse neurodevelopment outcomes in preterm infants

In-Depth [retrospective cohort study]: This population-based retrospective cohort study included all women aged 15 to 49 years who had an IA up to 14 completed weeks’ gestation in Ontario, Canada between 2017 and 2020. Patients who were non-Ontario residents, women without continuous  Ontario Health Insurance Plan eligibility within two years of the index pregnancy date, women with missing information on rurality or neighborhood income, and women who had IA done while admitted to the hospital as an inpatient were excluded from the study. The primary outcome measured was a composite of any serious adverse events, comprising severe maternal morbidity, maternal end-organ damage, intensive care unit admission, or death. Outcomes in the primary analysis were assessed via logistic regression and propensity scores. Based on the primary analysis, serious adverse events occurred among 133 women after mifepristone-misoprostol IA (3.3 per 1000) versus 114 after procedural IA (1.8 per 1000) (Relative Risk [RR] 1.87, 95% Confidence Interval [CI] 1.44 to 2.43; Absolute Risk Difference [ARD] 1.5 per 1000, 95%CI, 0.9 to 2.2). The respective rates of any adverse event were 28.9 versus 12.4 per 1000 (RR 2.33, 95%CI, 2.11 to 2.57; ARD 16.5 per 1000, 95%CI 14.5 to 18.4). The respective rates of any adverse event were 31.2 versus 24.9 per 1000 (RR 1.25, 95%CI 1.04 to 1.51). In summary, this study demonstrates that mifepristone-misoprostol IA, compared to procedural IA, may lead to an increased risk of short-term adverse events.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: abortionemergencygynecologyMifepristone-misoprostolobstetrics
Previous Post

Lecanemab may slow cognitive decline in early Alzheimer’s disease

Next Post

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

June 9, 2025
Stroke expansion following intra-arterial therapy may explain worse outcomes
Emergency

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

May 30, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Chronic Disease

Maternal hypertension associated with adverse neurodevelopment outcomes in preterm infants

May 10, 2025
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Vaccinations may be associated with small but temporary changes in menstrual cycle length

May 7, 2025
Next Post
No benefit of erlotinib in combined hepatocellular carcinoma treatment

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

Pediatric DKA associated with recent acute care visits

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis

Fibrinogen concentrate may be cost-effective for bleeding management in adult cardiac surgery patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
  • Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.